Tonix Pharmaceuticals Ownership 2024 | Who Owns Tonix Pharmaceuticals Now?


OverviewRevenueFinancialsChart

Institutional Ownership

0.00%

Insider Ownership

0.01%

Retail Ownership

99.99%

Institutional Holders

1.00

Tonix Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
IFP ADVISORS, INC----7-100.00%-Sep 30, 2023

Tonix Pharmaceuticals's largest institutional shareholder is IFP ADVISORS, INC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
IFP ADVISORS, INC----7-100.00%-Sep 30, 2023

The largest Tonix Pharmaceuticals shareholder by % of total assets is IFP ADVISORS, INC. The company owns 0.00 shares of Tonix Pharmaceuticals (TNXP), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
IFP ADVISORS, INC----7-100.00%-Sep 30, 2023

As of Sep 30 2023, Tonix Pharmaceuticals's largest institutional buyer is IFP ADVISORS, INC. The company purchased -7.00 stocks of TNXP, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
IFP ADVISORS, INC----7-100.00%-Sep 30, 2023

As of Sep 30 2023, Tonix Pharmaceuticals's biggest institutional seller is IFP ADVISORS, INC. The company sold -7.00 shares of TNXP, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
IFP ADVISORS, INC----7-100.00%-Sep 30, 2023

Tonix Pharmaceuticals's largest sold out institutional shareholder by shares sold is IFP ADVISORS, INC, sold -7.00 shares, valued at -, as of undefined.

Tonix Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
BRIDGEWAY FUNDS INC0.08%200,000--Dec 29, 2023
FIRST TRUST EXCHANGE-TRADED FUND VI0.04%172,793--Dec 31, 2023
PRUDENTIAL INVESTMENT PORTFOLIOS, INC.0.02%226,100--Dec 29, 2023
ETF Managers Trust0.02%150,526--Dec 31, 2023
BRIDGEWAY FUNDS INC0.01%30,000--Dec 29, 2023
VANGUARD INDEX FUNDS0.01%2,423,975--Dec 31, 2023
Voya VARIABLE PORTFOLIOS INC0.00%123,963--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%474,349--Feb 29, 2024
ALPS ETF Trust0.00%15,012--Feb 29, 2024
VANGUARD INDEX FUNDS0.00%513,588115,44329.00%Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%18,961--Feb 29, 2024
ETF Managers Trust0.00%5,922--Dec 31, 2023
ADVANCED SERIES TRUST0.00%2,491,500--Dec 29, 2023
PENN SERIES FUNDS INC0.00%12,100--Dec 29, 2023
NORTHERN FUNDS0.00%289,039--Dec 29, 2023
PRUDENTIAL INVESTMENT PORTFOLIOS 20.00%23,800--Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%843--Dec 31, 2023
MASSMUTUAL SELECT FUNDS0.00%38,738--Dec 31, 2023
VANGUARD SCOTTSDALE FUNDS0.00%53,786--Feb 29, 2024
MASTER INVESTMENT PORTFOLIO0.00%1,950--Dec 31, 2023
VALIC Co I0.00%5,797--Feb 29, 2024
Guggenheim Active Allocation Fund0.00%83--Feb 29, 2024
Dimensional ETF Trust0.00%2,074--Jan 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%411--Feb 29, 2024
iSHARES TRUST0.00%38,927--Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%3,900--Dec 31, 2023
RYDEX VARIABLE TRUST0.00%---Dec 31, 2023
Meeder Funds0.00%3--Mar 31, 2024
RYDEX SERIES FUNDS0.00%1--Dec 31, 2023
ProFunds0.00%1--Jan 31, 2024

Tonix Pharmaceuticals's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 200.00K shares, compromising 0.08% of its total assets.

Tonix Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 231-97.06%
31 Mar, 2334-2.86%
31 Dec, 223545.83%
30 Sep, 2224-31.43%
30 Jun, 2235-

As of 30 Jun 23, 1 institutions are holding Tonix Pharmaceuticals's shares, representing a decrease of -97.06% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 237-100.00%
31 Mar, 237,539,644-18.08%
31 Dec, 229,203,92365.21%
30 Sep, 225,570,88028.55%
30 Jun, 224,333,760-

Tonix Pharmaceuticals (TNXP) has 7.00 shares outstanding as of 30 Jun 23, down -100.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 230.00%-
31 Mar, 2374.38%0.90%
31 Dec, 2290.80%3.01%
30 Sep, 2254.96%3.01%
30 Jun, 2242.75%-

As of 30 Jun 23, Tonix Pharmaceuticals is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Mar 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 23--100.00%
31 Mar, 2315-34.78%
31 Dec, 222343.75%
30 Sep, 2216-54.29%
30 Jun, 2235-

- institutional shareholders have increased their position in TNXP stock as of 30 Jun 23 compared to 15 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 23--100.00%
31 Mar, 238-
31 Dec, 228100.00%
30 Sep, 224-
30 Jun, 22--

- institutional shareholders have reduced their position in TNXP stock as of 30 Jun 23 compared to 8 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 231-97.06%7-100.00%0.00%---100.00%--100.00%
31 Mar, 2334-2.86%7,539,644-18.08%74.38%0.90%15-34.78%8-
31 Dec, 223545.83%9,203,92365.21%90.80%3.01%2343.75%8100.00%
30 Sep, 2224-31.43%5,570,88028.55%54.96%3.01%16-54.29%4-
30 Jun, 2235-4,333,760-42.75%-35---

Tonix Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 16, 2023Stillwell Richard Newcombdirector-Sell83,000$0.56$46.65K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 06, 2024LEDERMAN SETHdirector, officer Chief Executive OfficerA-AwardBuy1,309,911$0.37$482.05K1,309,911
Feb 29, 2024LEDERMAN SETHdirector, officer Chief Executive OfficerA-AwardBuy1,903,680$0.46$875.69K1,903,680
Feb 29, 2024LEDERMAN SETHdirector, officer Chief Executive OfficerA-AwardBuy1,309,911$0.04$48.20K1,309,911
Feb 29, 2024LEDERMAN SETHdirector, officer Chief Executive OfficerA-AwardBuy235,320$0.37$86.60K235,320
Feb 29, 2024SAENGER BRADLEYofficer Chief Financial OfficerA-AwardBuy282,000$0.37$103.78K282,000
Feb 29, 2024SAENGER BRADLEYofficer Chief Financial OfficerA-AwardBuy282,000$0.46$129.72K282,000
Feb 29, 2024MORRIS JESSICA EDGARofficer Chief Operating OfficerA-AwardBuy317,000$0.37$116.66K317,000
Feb 29, 2024MORRIS JESSICA EDGARofficer Chief Operating OfficerA-AwardBuy317,000$0.46$145.82K317,000
Feb 29, 2024SULLIVAN GREGORY Mofficer Chief Medical OfficerA-AwardBuy358,000$0.37$131.74K358,000
Feb 29, 2024SULLIVAN GREGORY Mofficer Chief Medical OfficerA-AwardBuy358,000$0.46$164.68K358,000
May 10, 2023BAGGER RICHARD Hdirector-A-AwardBuy60,000$0.51$30.54K60,000
May 10, 2023Bell Margaret Smithdirector-A-AwardBuy60,000$0.51$30.54K60,000
May 10, 2023GRANGE DAVID Ldirector-A-AwardBuy60,000$0.51$30.54K60,000
May 10, 2023OLUKOTUN ADEOYE Ydirector-A-AwardBuy60,000$0.51$30.54K60,000
May 10, 2023Stillwell Richard Newcombdirector-A-AwardBuy60,000$0.51$30.54K60,000
May 10, 2023Taylor Carolyn E.director-A-AwardBuy60,000$0.51$30.54K60,000
May 10, 2023Treco Jamesdirector-A-AwardBuy60,000$0.51$30.54K60,000
Mar 16, 2023Stillwell Richard Newcombdirector-A-AwardBuy83,000$0.56$46.65K83,000
Mar 16, 2023Stillwell Richard Newcombdirector-Sell83,000$0.56$46.65K-
Feb 24, 2023SULLIVAN GREGORY Mofficer Chief Medical OfficerA-AwardBuy220,000$0.73$160.82K220,000

The last insider sell of Tonix Pharmaceuticals's stock was made by Stillwell Richard Newcomb on Mar 16 2023, selling 83,000 shares at $0.56 per share (valued at $46.65K).

Tonix Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 20249--
Q2 20237--
Q1 202391900.00%
Q2 202210--
Q1 202217--
Q4 2021---
Q3 202121200.00%
Q2 202181800.00%
Q1 202110--
Q4 20201--
Q3 20207--
Q2 20201511500.00%
Q1 20209--
Q4 20191--
Q2 20191611600.00%
Q1 20191111100.00%
Q3 201811100.00%
Q2 20181911900.00%
Q1 2018112550.00%
Q4 20171616.67%

9 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Tonix Pharmaceuticals's insiders, as of Q1 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2024---
Q2 2023---
Q1 2023---
Q2 20221--
Q1 20221--
Q4 2021---
Q3 20211--
Q2 20211--
Q1 20211--
Q4 20201--
Q3 20207--
Q2 2020---
Q1 2020---
Q4 20191--
Q2 2019---
Q1 20192--
Q3 2018---
Q2 201811--
Q1 2018---
Q4 20171616.67%

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Tonix Pharmaceuticals's stocks.

Tonix Pharmaceuticals Peer Ownership


TickerCompany
VRAXVirax Biolabs Group Limited
CWBRCohBar, Inc.
JAGXJaguar Health, Inc.
PALIPalisade Bio, Inc.
VBIVVBI Vaccines Inc.
DFFNCervoMed Inc.
VXRTVaxart, Inc.
INOInovio Pharmaceuticals, Inc.
ENVBEnveric Biosciences, Inc.
ONTXTraws Pharma, Inc.
ACSTAcasti Pharma Inc.
NVAXNovavax, Inc.
SONNSonnet BioTherapeutics Holdings, Inc.
DRUGBright Minds Biosciences Inc.

TNXP Ownership FAQ


Tonix Pharmaceuticals is owned by institutional shareholders (0.00%), insiders (0.01%), and public (99.99%). The largest institutional shareholder of Tonix Pharmaceuticals is IFP ADVISORS, INC (0% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.08% of total shares).

Tonix Pharmaceuticals's major institutional shareholders are IFP ADVISORS, INC. The top five shareholders own together 0% of the company's share outstanding.

As of Jun 2023, there are 1 institutional shareholders of Tonix Pharmaceuticals.

IFP ADVISORS, INC owns 0 shares of Tonix Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).